Skip to main content

Breadcrumb

  1. Home

Outpatient Services

Back Pain: Physical Exam

Percentage of patients at least 18 years of age and younger than 80 with a back pain episode of 28 days or more with documentation of a physical examination on the date of the initial visit with the physician.

CBE ID
0319

Back Pain: Recommendation for Exercise

Percentage of patients at least 18 years of age and younger than 80 with back pain lasting more than 12 weeks, with documentation of physician advice for supervised exercise.

CBE ID
0317

Back Pain: Repeat Imaging Studies

Percentage of patients at least 18 years of age and younger than 80 with a back pain episode of 28 days or more who received inappropriate repeat imaging studies in the absence of red flags or progressive symptoms (overuse measure, lower performance is better).

CBE ID
0312

Back Pain: Shared Decision Making

Percentage of patients at least 18 years of age and younger than 80 with back pain with whom a physician or other clinician reviewed the range of treatment options, including alternatives to surgery prior to surgery. To demonstrate shared decision making, there must be documentation in the patient record of a discussion between the physician and the patient that includes all of the following.
1) Treatment choices, including alternatives to surgery;
2) Risks and benefits;
3) Evidence of effectiveness

CBE ID
0310

Back Pain: Surgical Timing

Percentage of patients at least 18 years of age and younger than 80 with a back pain episode of 28 days or more without documentation of red flags who had surgery within the first six weeks of back pain onset (overuse measure, lower performance is better).

Note: This measure is applicable only for physicians who perform surgery.

CBE ID
0305

Barrett´s Esophagus

Percentage of patients with esophageal biopsy reports for Barrett’s esophagus that contain a statement about dysplasia and if present the grade of dysplasia.

CBE ID
1854

Bipolar Disorder: Assessment for diabetes

Percentage of patients treated for bipolar disorder who are assessed for diabetes within 16 weeks after initiating treatment with an atypical antipsychotic agent.

CBE ID
0003